Ese wigeze wumva indwara ya kanseri y'amaraso idakira (CLL)? Reka tubiganireho birambuye!

Ese rimwe na rimwe wumva unaniwe cyane? Cyangwa ukunze kugira umuriro? Ese ufite utubyimba duto twumva nk'aho turi ku ijosi ryawe, mu kwaha, cyangwa mu kibuno? Ibi bishobora kuba ibimenyetso bya Leukemia idakira ya Lymphocytic, cyangwa CLL mu magambo make. Ariko ntugahangayike, kuko kugira ibi bimenyetso byose ntibivuze ko ufite iyi ndwara. Ariko ni ngombwa cyane kumenya ibintu nk'ibi. Reka tuvuge kuri CLL mu buryo bworoshye uyu munsi, sibyo?

Leukemia idakira ya lymphocytic (CLL) ni iki? Mu magambo make...

Leukemia idakira ya lymphocytic (CLL) ni ubwoko bwa kanseri y'amaraso . Ni yo ndwara ikunze kugaragara cyane mu bantu bakuru. Uturemangingo tw'amaraso tuboneka mu musemburo w'amagufwa. Iyi ndwara ibaho iyo lymphocytes, ubwoko bw'uturemangingo tw'amaraso tw'umweru mu musemburo w'amagufwa, tubaye ibisanzwe, bivuze ko duhinduka tukaba kanseri. Utu turemangingo twa kanseri twiyongera mu buryo butunguranye, tugapfukirana uturemangingo tw'amaraso n'udupira tw'amaraso, bifasha amaraso kubumba.

Indwara ya CLL ikunze kugaragara ku bantu barengeje imyaka 65. Ariko, rimwe na rimwe ishobora kugaragara ku bantu bafite imyaka 30. Ikindi kandi, hari abantu bashobora kurwara CLL badafite ibimenyetso . Abantu benshi babimenya iyo bapimye amaraso yabo kugira ngo babone indi ndwara cyangwa iyo bapimwe buri mwaka ngarukamwaka.

Ubu, nta muti uhari wa CLL. Ariko ibyo si ikibazo giteye impungenge. Mu myaka icumi ishize, abaganga bavumbuye uburyo bushya bwo kuvura CLL no kuyigabanya . Ubu buryo bwo kuvura bwatumye abantu barwaye CLL baramba cyane.

Ni ubuhe bwoko bw'ingenzi bwa CLL?

Hari ubwoko bubiri bw'ingenzi bw'uturemangingo tw'amaraso twera mu mibiri yacu, bwitwa lymphocytes. CLL ishobora kuvuka muri bumwe muri ubwo bwoko bubiri gusa.

• B-lymphocytes (B-cells): Izi ni uturemangingo dukora uturemangingo, ubwoko bwa poroteyine imenya kandi ikarwanya mikorobe zangiza, bagiteri, virusi, ndetse n'uturemangingo twa kanseri.
• T-lymphocytes (T-cells): Izi zigenzura uko ubudahangarwa bw'umubiri bukora mu mubiri wacu. Zisanga kandi zikanasenya uturemangingo tudasanzwe, nk'uturemangingo twa kanseri.

Ubwoko bwa CLL bukunze kugaragara cyane ni B-cell CLL . Hari indwara ifitanye isano n'iyi ifata T-cells, yitwa T-cell prolymphocytic leukemia (PLL). Ariko, abantu barwaye PLL bagaragaza ibimenyetso vuba kurusha abantu barwaye B- cell CLL.

Iyi ndwara yitwa CLL ikunze kugaragara gute?

Mu by’ukuri, kanseri y’ibihaha ifata abantu bakuru (CLL) ni imwe mu ndwara zikunze kugaragara cyane mu bantu bakuru. Muri Leta Zunze Ubumwe za Amerika, iyi ndwara yibasira abantu bagera kuri 5 kuri 100.000. Umuryango w’Abanyamerika urwanya kanseri uteganya ko hazabaho abantu bashya bagera ku 18.700 banduye kanseri y’ibihaha mu 2023 gusa. Kugira ngo tubisobanure neza, abantu barenga 238.000 barwaye kanseri y’ibihaha (imwe muri kanseri zikunze kugaragara cyane) biteganijwe ko bazagaragara muri 2023. Nubwo CLL isa nkaho idakunze kugaragara cyane, ni imwe mu ndwara zikunze kugaragara cyane mu ndwara z’ibihaha.

Ni ibihe bimenyetso bya CLL?

Nkuko twabivuze mbere, hari abantu bashobora kurwara CLL badafite ibimenyetso . Bishobora gufata amezi cyangwa imyaka kugira ngo ibimenyetso bigaragare. Ibimenyetso bikunze kugaragara ni ibi bikurikira:

• Umunaniro: CLL ishobora kugira ingaruka ku turemangingo dutukura tw'amaraso yawe, bigatera kubura amaraso. Umunaniro ni ikimenyetso gisanzwe cy'amaraso make.
• Umuriro: Umuriro ni ikimenyetso cy'ubwandu. Kubera ko CLL igira ingaruka ku turemangingo tw'amaraso tw'umweru tuzima, uba ufite amahirwe menshi yo kwandura indwara.
• Utunyangingo tw’imitsi tubyimba mu ijosi, mu kwaha, mu kibuno, cyangwa mu nda.
• Kubira ibyuya nijoro.
• Kugabanya ibiro mu buryo budasanzwe.
• Ububabare cyangwa kumva wuzuye munsi y'imbavu zawe: CLL ishobora kugira ingaruka ku mwijima wawe cyangwa ku muheha. Iyo uturemangingo twa kanseri twirundanyije muri izi ngingo, dushobora kubyimba.

Kuki CLL ikura? Ni ibihe bintu bishobora gutera ibyago?

Leukemia y'uruhererekane rw'amaraso mu maraso (CLL) ibaho iyo hari impinduka zimwe na zimwe, cyangwa impinduka, zibayeho muri chromosomes na genes zacu mu gihe cy'ubuzima bwacu. Nyamara, abashakashatsi mu by'ubuvuzi ntibaramenya neza icyatera izi mpinduka. Ariko, bagaragaje ibintu byinshi bishobora kugira ingaruka kuri yo:

• Amateka y'umuryango: Ubushakashatsi bwagaragaje ko iyo umwe mu bavandimwe bawe ba hafi, ni ukuvuga mama wawe, so wawe, abavandimwe bawe, cyangwa abana bawe, afite CLL, ibyago byawe byo kurwara CLL bishobora kwiyongeraho inshuro ebyiri kugeza kuri enye.
• Imyaka: Ugereranyije, abarwayi baba bafite imyaka 71 iyo basanzwe barwaye CLL.
• Igitsina: Abagabo bafite amahirwe menshi yo kurwara CLL.
• Guhura na Agent Orange: Ubushakashatsi bwagaragaje isano iri hagati ya Agent Orange, ikinyabutabire cyakoreshejwe mu ntambara ya Vietnam, na CLL.
• Lymphocytosis y'uturemangingo twa B-monoclonal:Muri iki kibazo, uba ufite ubwoko bumwe bwa B-cell mu maraso yawe kurusha uko bisanzwe. Iyo ufite iki kibazo, uba ufite ibyago bike byo kurwara CLL.

Ni izihe ngorane zishobora guterwa na CLL?

CLL igira ingaruka ku tunyangingo tw’amaraso dutukura, uturemangingo tw’amaraso twera, na plaquettes. Tekereza nawe, uturemangingo tw’amaraso dutukura dutwara umwuka wa ogisijeni mu mubiri wose. Uturemangingo tw’amaraso twera tuturinda indwara. Uturemangingo dufasha amaraso kubumba. Rero, iyo utakaje uturemangingo tw’amaraso tuzima na plaquettes, ushobora kugira ingorane nka:

• Lymphoma: Hagati ya 2% na 10% by'abantu barwaye CLL bashobora kurwara ubwoko bwa kanseri yitwa lymphoma.
• Kanseri y'uruhu, kanseri y'ibihaha, cyangwa kanseri y'amara: CLL igabanya ubudahangarwa bw'umubiri wawe, bigatuma idashobora kukurinda abakwibasira, harimo n'uturemangingo twa kanseri. Ibi bishobora kongera ibyago byo kurwara ubundi bwoko bwa kanseri.
• Anemia: Anemia ishobora kubaho iyo nta turemangingo dutukura duhagije two gutwara ogisijeni mu mubiri wose.
• Thrombocytopenia: CLL ishobora kugira ingaruka ku mikorere ya platelet yawe. Ibi bishobora gutera kuva amaraso.
• Kwandura indwara zikunze kugaragara: Udafite uturemangingo tw’amaraso twera dufite ubuzima bwiza, uba ufite amahirwe menshi yo kwandura indwara za bagiteri, fungal, cyangwa virusi.
• Indwara ziterwa n'ubwirinzi bw'umubiri: Bamwe mu bantu bafite CLL bashobora kurwara indwara nka anemia y'amaraso iterwa n'ubwirinzi bw'umubiri.

Ni gute CLL ipimwa?

Iyo ugiye kwa muganga, azakubaza ibimenyetso byawe. Hanyuma, bazagukorera isuzuma ry’umubiri kandi bashobora no kugutegeka ibizamini bimwe na bimwe, urugero:

• Umubare wuzuye w'amaraso (CBC) n'itandukaniro: Iki kizamini gipima umubare w'uturemangingo dutukura tw'amaraso, uturemangingo twera tw'amaraso, na plaquettes mu maraso yawe. Kinagenzura ingano ya hemoglobin (poroteyine itwara ogisijeni) mu turemangingo dutukura tw'amaraso yawe.
• Gupima amaraso yo mu mpande: Umuhanga mu bya laboratwari asuzuma uturemangingo tw’amaraso yawe akoresheje mikorosikopi kugira ngo arebe niba nta turemangingo twa kanseri dufite.
• Isuzuma rya "flow cytometry": Iki kizamini cya laboratwari gishobora gutanga amakuru menshi ku turemangingo tw'amaraso yawe. Muri CLL, gikoreshwa mu kumenya neza niba uturemangingo tw'amaraso yawe tw'umweru dufite uturemangingo twa CLL.
• Ibipimo by'uturemangingo:Abaganga bakoresha ibizamini nka fluorescent in situ hybridization (FISH) na immunoglobulin heavy chain (IGHV) kugira ngo basuzume chromosomes na genes zawe. Gusobanukirwa impinduka zabaye muri izi chromosomes na genes bifasha abaganga gufata icyemezo cy'uko bavura CLL.

Ibyiciro bya CLL

Abaganga ni bo bagena icyiciro cya kanseri kugira ngo bategure uburyo bwo kuyivura no guhanura igihe izabera. Hari uburyo bubiri bw'ingenzi bukoreshwa mu gupima CLL: uburyo bwa Rai staging system na Binet staging system .

Hari igihe iyo usomye ibi byiciro mu mibare n'inyuguti, ushobora kumva ufite ubwoba kandi ukumva utameze neza. Ushobora no gutekereza uti "Ese uku niko indwara yanjye isobanurwa mu buryo runaka?" Abaganga barabyumva. Niba utasobanukiwe neza ibirimo kuvugwa, cyangwa niba bikugoye, saba muganga wawe agusobanurire uburyo ubu buryo bw'ibyiciro bukoreshwa ku ndwara yawe.

Sisitemu yo gupima Rai

Ubu buryo bushyira CLL mu byiciro hakurikijwe amahirwe yo kuyongera ndetse niba hazakenerwa ubuvuzi:

• Ingaruka nke (yahoze yitwa Rai stage 0): Ufite lymphocytosis (ubwiyongere bw'umubare wa lymphocytes), kandi hari uturemangingo tw'amaraso tudasanzwe mu maraso cyangwa mu musokoro w'amagufwa.
• Ingaruka z’ubukana bw’indwara (cyahoze cyitwa Rai icyiciro cya mbere cyangwa icyiciro cya kabiri): Ufite lymphocytosis, lymph nodes zibyimbye, hamwe n’umwijima cyangwa urwagashya.
• Ingaruka zikomeye (zahoze zizwi nka Rai Stage III): Ufite ikibazo cyo kubura amaraso cyangwa thrombocytopenia (umubare muto wa platelet).

Sisitemu yo gupima ibice bya binet

Ubu buryo bushingiye ku mibare y'uturemangingo tw'amaraso n'udukoko twa platelet, ndetse n'umubare w'ahantu hari utudomo twa lymph twabyimbye mu mubiri wawe:

• Icyiciro cya A: Ntabwo ufite amaraso make (umubare muto w’uturemangingo dutukura mu maraso) cyangwa platelets nke. Ariko, ufite lymph nodes zabyimbye nibura ahantu habiri ku mubiri wawe. Urugero, ushobora kugira lymph nodes zabyimbye mu ijosi no mu nda.
• Icyiciro cya B: Hari utunyangingo twa lymph twabyimbye ahantu hatatu ku mubiri, cyangwa umwijima cyangwa urwagashya birabyimbye. Ariko, nta anemia ibaho, kandi urugero rwa platelet ni rusanzwe.
• Icyiciro cya C: Ufite ikibazo cyo kubura amaraso no kubyimba kw'imitsi mu bice bitatu cyangwa birenga ku mubiri wawe.

CLL ivurwa ite?

Uburyo bwo kuvura bugenwa n'ibimenyetso byawe n'ibisubizo by'ibizamini. Urugero, niba ufite CLL mu gihe cya mbere, muganga wawe ashobora kukugira inama yo "gutegereza witonze/gukurikiranwa neza."Ushobora gukoresha uburyo bwitwa "gukurikirana." Ibi bikubiyemo gukurikirana witonze ubuzima bwawe muri rusange, ibimenyetso, n'ibisubizo by'ibizamini udatangiye kuvurwa.

Ibisubizo by'ibizamini bya genetiki bishobora no kugira ingaruka ku byemezo byo kuvura. Urugero, impinduka zimwe na zimwe za genetiki zishobora gutuma indwara yawe irushaho kuba mbi vuba, cyangwa ko ubuvuzi busanzwe bwa CLL bushobora kudakora neza nk'uko byari byitezwe.

Uburyo bukunze gukoreshwa mu kuvura CLL ni uburyo bwo kuvura bugamije kuvura indwara zitandukanye (chimiotherapie) . Hari igihe ubuvuzi bushingiye ku mirasire bukoreshwa mu kugabanya ibimenyetso bya CLL. Buri buryo muri ubu buryo bushobora gutera ingaruka zitandukanye. Muganga wawe azagusobanurira neza ibyiza, ingaruka mbi, n'ingorane zishobora kubaho mu gihe kirekire z'ubuvuzi urimo guhabwa.

Ubuvuzi bwibasiwe

Ubu buvuzi bukora hibandwa ku tunyangingo twa kanseri. Mu ndwara ya kanseri y’amaraso idakira, ubu buvuzi bukora hibandwa ku gukura kw’utunyangingo tw’amaraso tw’umweru twa kanseri. Bumwe mu buryo bukoreshwa bwica utwo tunyangingo twa kanseri butagize ingaruka ku tunyangingo tuzima. Imwe mu miti ikoreshwa muri ibi ni:

• Uburyo bwo kuvura indwara ya Bruton's tyrosine kinase (BTK): Ubu buryo bwo kuvura buhagarika enzyme ifasha uturemangingo twa B gukora uturemangingo twinshi tw’amaraso. Urugero: ibrutinib (Imbruvica®) , acalabrutinib (Calquence®) , na zanubrutinib (Brukinsa ®) .
• Uburyo bwo kuvura indwara ya BCL2: Umuti wa venetoclax (Venclexta®) ubuza poroteyine yitwa BCL2 iboneka mu turemangingo twa leukemia, harimo n'uturemangingo twa CLL. Ubu buryo bwo kuvura bushobora kwica uturemangingo twa leukemia cyangwa bukarushaho kuba bwiza ku yindi miti irwanya kanseri.
• Uburyo bwo kuvura indwara zo mu bwoko bwa monoclonal antibody: Ubu ni ubwoko bwa immunotherapy. Udukoko two mu bwoko bwa monoclonal ni ubwoko bwa antibody ikorerwa muri laboratwari. Ihagarika gukura kw'uturemangingo twa kanseri cyangwa ikica uturemangingo twa kanseri. Urugero: rituximab (Rituxan®) na obinutuzumab (Gazyva®) .

Ubuvuzi bwa Chimiotherapie

Muganga wawe ashobora gukoresha imiti ya chimiotherapie nk'uburyo bw'ibanze bwo kuvura kanseri y'amaraso idakira. Imwe mu miti ya chimiotherapie ikoreshwa cyane muri CLL ni:

• Fludarabine (Fludarabine - Fludara®)
• Chlorambucil (Chlorambucil - Leukeran®)
• Cyclophosphamide (Cytoxan®)
• Bendamustine (Bendamustine - Treanda®)

Ubudahangarwa bw'umubiri

Ubu buryo bwo kuvura bukora mu kugarura cyangwa gukomeza ubudahangarwa bw'umubiri wawe, bugafasha mu gusenya uturemangingo twa kanseri cyangwa kugabanya imikurire yatwo.

Ku ndwara ya CLL itarakira imiti ya chimiotherapie, yagarutse (isubira) CLL, cyangwa irimo kwiyongera, abaganga bashobora gukoresha umuti wa lenalidomide (Revlimid®) uvura indwara z’umubiri.

Abashakashatsi mu by'ubuvuzi barimo kwiga uburyo bwo kuvura indwara ya chimeric antigen receptor (CAR-T) ku barwayi ba CLL batemera ubuvuzi busanzwe.

Ushobora kumarana igihe kingana iki na CLL?

Leukemia idakira ya lymphocytic (CLL) ikunze kugenda buhoro cyane. Ushobora kubana na CLL imyaka myinshi mbere yuko ugaragaza ibimenyetso. Iyo ibimenyetso bigaragaye, abaganga bagira uburyo bwiza bwo kuvura bushobora gutuma CLL igabanuka . Ubu buryo bwo kugabanya CLL bukunze kumara imyaka myinshi mbere yuko indwara igaruka. Ariko, muganga wawe ashobora kukugira inama y'ubundi buryo bwo kuvura bushobora kongera gutuma CLL igabanuka. CLL ntikira burundu, ariko abantu barwaye iyo ndwara bashobora kubaho igihe kirekire kandi cyuzuye.

Ikigo cy’Igihugu gishinzwe kurwanya kanseri kivuga ko 87.9% by’abarwayi ba CLL baba bakiriho nyuma y’imyaka itanu banduye. Ariko, iyo utekereje kuri ibi bipimo byo kubaho, ni ngombwa kwibuka ko ibi bipimo bishingiye ku bunararibonye bw’itsinda rinini ry’abarwayi ba CLL. Hari ibintu byinshi bishobora kugira ingaruka kuri ibi bipimo byo kubaho, harimo ubuzima bwawe muri rusange, aho indwara yawe igeze mu gihe cyo kuyisuzuma, ndetse n’uburyo indwara yawe yakira neza iyo uyivuwe. Niba ufite ibibazo, baza muganga wawe icyo wakwitega bitewe n’imimerere yawe.

Ni iki kibaho mu cyiciro cya nyuma cya CLL?

Ijambo "intambwe ya nyuma" risobanura ko uburyo bwo kuvura butagikora mu kugenzura cyangwa guhagarika indwara ya CLL. Muri icyo gihe, ushobora kugira indwara zishobora kuguhitana cyangwa kuva amaraso mu buryo budasubirwaho abaganga bashobora kutabasha kuvura.

Ese iki kibazo gishobora kwirindwa?

Kugeza ubu nta buryo buzwi bwo gukumira CLL.

Bimeze bite kubana na CLL?

Biterwa n'uko umeze. Ushobora kurwara CLL udafite ibimenyetso. Niba ufite ibimenyetso, hari uburyo bwo kugabanya no gucunga indwara. Ariko, indwara ntizashira burundu.

Dore inama zimwe na zimwe zishobora kugufasha mu gihe ubana na CLL:

• Irinde kwandura indwara:Abantu barwaye CLL bafite ibyago byinshi byo kwandura indwara. Hari indwara zimwe na zimwe zishobora gushyira ubuzima mu kaga. Baza muganga wawe inkingo zikubereye.
• Menya ubuzima bwawe muri rusange: Ushobora kuba ufite ibyago byinshi byo kurwara kanseri y'uruhu, kanseri y'ibihaha, cyangwa kanseri y'amara. Baza muganga wawe ibijyanye n'ibizamini byo gupima kanseri.
• Gucunga imihangayiko: Abantu benshi barwaye CLL bahura n'ibihe byo koroherwa no kongera kurwara. Uko indwara ikomeza kwiyongera, ushobora kumva uhangayitse kandi ufite ubwoba. Niba ari uko bimeze, baza muganga wawe gahunda cyangwa serivisi zishobora kugufasha gucunga imihangayiko yawe.
• Kurya indyo yuzuye: Ibimenyetso bimwe na bimwe bya CLL bishobora gutuma utakaza ubushake bwo kurya. Vugana na muganga wawe ku bijyanye no kubona inama ku nzobere mu by'imirire. Niba ubushake bwawe bwo kurya ari bwiza, gerageza kurya indyo yuzuye irimo poroteyine zitarimo ibinure, ibinyampeke byuzuye, imbuto n'imboga, n'ibinure byiza. Ibi bishobora kunoza ubuzima bwawe muri rusange.
• Imyitozo ngororamubiri: Imyitozo ngororamubiri igufasha gucunga imihangayiko no kugukomeza kugira ibyishimo.
• Kuruhuka: CLL ishobora gutuma wumva unaniwe cyane. Kuruhuka iyo wumva ukeneye kuruhuka.
• Menya icyo witeze: Ubumenyi ni imbaraga. Baza muganga wawe ibimenyetso byerekana ko indwara yawe ishobora kuba irushaho kuba mbi. Niba ari uko bimeze, muganga wawe ashobora kukugira inama y'ubundi buryo bwo kuvura bushobora gufasha mu kuvura CLL yawe neza.

Ni ibihe bibazo ngomba kubaza muganga wanjye?

Ushobora kubaza ibibazo nk'ibi:

• Ni ubuhe bwoko bwa leukemia idakira ya lymphocytic mfite?
• Nta bimenyetso mfite. Ni ryari nkwiye gutangira kuvurwa?
• Ni ubuhe buryo bwo kuvura mfite?
• Ese nzagomba kuvurwa ubuziraherezo?
• Ese kuvurwa bizagabanya ikibazo cyanjye?

Amaherezo, ibintu byo kwibuka (Ubutumwa bwo kujyana mu rugo)

Leukemia idakira ya lymphocytic (CLL) ni ubwoko bwa leukemia bukunze kugaragara ku bantu bakuru. Ushobora kugira iyi ndwara imyaka myinshi nta bimenyetso. Niba ufite CLL, ushobora kudahita utangira kuyivura. Nubwo abaganga badashobora kuyivura burundu, hari uburyo bwo kuvura bushobora kugabanya ibimenyetso bya CLL no gutuma indwara igabanuka . Hari abantu barwaye CLL bamara imyaka myinshi.

Kubana n'indwara idakira nka CLL ntibyoroshye buri gihe. Ushobora kunyura mu byiciro bitandukanye byo koroherwa no kongera kurwara. Muri buri cyiciro, ushobora guhangayikishwa n'ibizakurikiraho. Abaganga bawe basobanukiwe uko kubana n'indwara idakira bimeze. Bazishimira gusubiza ibibazo byose ushobora kuba ufite kandi bakagufasha mu buryo bwose bushoboka. Rero, ntugatinye kuvugana na muganga wawe ku bibazo byawe.

Leukemia , CLL, kanseri y'amaraso, ibimenyetso, uburyo bwo kuvura, limfozeti, gukira